Cajal Therapeutics

Developer of disease-altering therapies intended for the treatment of neurodegenerative diseases. The company creates viral tools and platforms to screen for the targets with functional impact on neur...

Healthcare

Seattle, WA, United States

Founded 2020

60 employees

Website

Valuation

$139M

Market implied

Share Price

N/A

Total Raised

$135.7M

Last Round

N/A

Investors

+9 other investors

View all 9 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Cajal Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required